JPH07509475A - 医薬 - Google Patents
医薬Info
- Publication number
- JPH07509475A JPH07509475A JP6504996A JP50499694A JPH07509475A JP H07509475 A JPH07509475 A JP H07509475A JP 6504996 A JP6504996 A JP 6504996A JP 50499694 A JP50499694 A JP 50499694A JP H07509475 A JPH07509475 A JP H07509475A
- Authority
- JP
- Japan
- Prior art keywords
- propellant
- formulation
- beclomethasone dipropionate
- hydrogen
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.粒状ジプロピオン酸ベクロメタソンまたはその薬学上許容される溶媒和物を 、フルオロカーボンまたは水素含有クロロフルオロカーボン噴射剤とともに含ん でなり、界面活性剤を実質上含有していない、医薬エアゾール処方物。 2.粒状ジプロピオン酸ベクロメタソン−1,1,1,2−テトラフルオロエタ ン溶媒和物を、フルオロカーボンまたは水素含有クロロフルオロカーボン噴射剤 とともに含んでなり、界面活性剤を実質上含有していない、医薬エアゾール処方 物。 3.粒状無水ジプロピオン酸ベクロメタソンを、フルオロカーボンまたは水素含 有クロロフルオロカーボン噴射剤とともに含んでなり、界面活性剤を実質上含有 していない、医薬エアゾール処方物。 4.噴射剤が1,1,1,2−テトラフルオロエタンである、請求項1〜3のい ずれか一項に記載の処方物。 5.噴射剤が1,1,1,2,3,3,3−ヘプタフルオロ−n−プロパンであ る、請求項1〜3のいずれか一項に記載の処方物。 6.処方物の全重量に対して0.005〜5.0%W/Wのジプロピオン酸ベク ロメタソンを含有してなる、請求項1〜5のいずれか一項に記載の処方物。 7.サルブタモールを更に含有してなる、請求項1〜6のいずれか一項に記載の 処方物。 8.ジプロピオン酸ベクロメタソン−1,1,1,2−テトラフルオロエタン溶 媒和物と、1種以上のフルオロカーボンまたは水素含有クロロフルオロカーボン 噴射剤とから本質的になる、医薬エアゾール処方物。 9.噴射剤が1,1,1,2−テトラフルオロエタンである、請求項8に記載の 処方物。 10.無水ジプロピオン酸ベクロメタソン、および噴射剤としての1,1,1, 2.3,3,3−ヘプタフルオロ−n−プロパンとから本質的になる、医薬エア ゾール処方物。 11.用いられる噴射剤の蒸気圧に耐えうる容器からなり、該容器が計量バルブ で閉じられて、粒状ジプロピオン酸ベクロメタソンまたはその薬学上許容される 溶媒和物を、フルオロカーボンまたは水素含有クロロフルオロカーボン噴射剤と ともに含んでなる医薬エアゾール処方を含有しており、その処方が界面活性剤を 実質上含有していないものである、医薬エアゾール処方を送達するのに適した容 器。 12.適切な導管装置中に装填された請求項11に記載の容器を含んでなる、計 量吸入器。 13.粒状ジプロピオン酸ベクロメタソンまたはその薬学上許容される溶媒和物 を、フルオロカーボンまたは水素含有クロロフルオロカーボン噴射剤とともに含 んでなり、界面活性剤を実質上含有していない医薬エアゾール処方物の有効量を 吸入投与することからなる、呼吸障害の治療方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929216381A GB9216381D0 (en) | 1992-07-31 | 1992-07-31 | Medicaments |
GB9216382.3 | 1992-07-31 | ||
GB929216382A GB9216382D0 (en) | 1992-07-31 | 1992-07-31 | Medicaments |
GB9216381.5 | 1992-07-31 | ||
PCT/EP1993/002040 WO1994003153A1 (en) | 1992-07-31 | 1993-07-30 | Surfactant free aerosol formulations containing beclomethasone dipropionate |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH07509475A true JPH07509475A (ja) | 1995-10-19 |
Family
ID=26301356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6504996A Pending JPH07509475A (ja) | 1992-07-31 | 1993-07-30 | 医薬 |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP0658101B1 (ja) |
JP (1) | JPH07509475A (ja) |
CN (1) | CN1052401C (ja) |
AT (2) | ATE162709T1 (ja) |
AU (1) | AU670616B2 (ja) |
DE (2) | DE69333187T2 (ja) |
DK (1) | DK0658101T3 (ja) |
ES (2) | ES2206619T3 (ja) |
GR (1) | GR3026185T3 (ja) |
MX (1) | MX9304585A (ja) |
WO (1) | WO1994003153A1 (ja) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
WO1994021386A2 (en) * | 1993-03-25 | 1994-09-29 | Research Corporation Technologies, Inc. | Polymers useful in forming self-assembled bonded anisotropic ultrathin layers and their use |
US5508023A (en) * | 1994-04-11 | 1996-04-16 | The Center For Innovative Technology | Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant |
GB9425160D0 (en) * | 1994-12-10 | 1995-02-08 | Glaxo Group Ltd | Medicaments |
US5747001A (en) * | 1995-02-24 | 1998-05-05 | Nanosystems, L.L.C. | Aerosols containing beclomethazone nanoparticle dispersions |
NZ306281A (en) * | 1995-04-14 | 1999-07-29 | Glaxo Wellcome Inc | Metered dose inhaler with part or all internal surfaces coated with fluorocarbon polymers for dispensing beclomethasone dipropionate |
BR9604976A (pt) * | 1995-04-14 | 1998-06-09 | Glaxo Wellcome Inc | Inalador de dose medida sistema inalador de dose medida e uso do mesmo |
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
US6068832A (en) * | 1996-08-29 | 2000-05-30 | Schering Corporation | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
BR9810409A (pt) * | 1997-03-18 | 2000-08-22 | Basf Ag | Métodos e composições para a modulação de responsividade a corticosteróides |
US6054487A (en) * | 1997-03-18 | 2000-04-25 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US6433040B1 (en) | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
US6086376A (en) * | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
US20060171899A1 (en) * | 1998-12-10 | 2006-08-03 | Akwete Adjei | Water-stabilized aerosol formulation system and method of making |
EP1169019B1 (en) | 1999-04-14 | 2003-02-26 | Glaxo Group Limited | Pharmaceutical aerosol formulation |
US6540982B1 (en) * | 2000-01-25 | 2003-04-01 | Aeropharm Technology Incorporated | Medical aerosol formulation |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US7442388B2 (en) | 2000-05-10 | 2008-10-28 | Weers Jeffry G | Phospholipid-based powders for drug delivery |
AU2002234476B2 (en) * | 2001-03-30 | 2006-04-27 | Jagotec Ag | Medical aerosol formulations |
US6455028B1 (en) | 2001-04-23 | 2002-09-24 | Pharmascience | Ipratropium formulation for pulmonary inhalation |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
CA2468958C (en) | 2001-12-19 | 2012-07-03 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
CN100369608C (zh) * | 2006-03-15 | 2008-02-20 | 修涞贵 | 一种治疗过敏性鼻炎的混悬液型喷雾剂及制备方法 |
BRPI0719825A2 (pt) * | 2006-10-12 | 2014-05-06 | Koninkl Philips Electronics Nv | Sistema de detecção e método para detectar pelo menos uma molécula alvo |
CA2677838C (en) | 2007-02-11 | 2017-08-01 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1429184A (en) | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
IT1121513B (it) | 1979-05-28 | 1986-04-02 | Chiesi Farma Spa | Processo per la conversione di umo steroide antiinfiammatorio in una forma suscettibile di essere somministarta come aerosol |
EP0039369B1 (en) * | 1980-05-02 | 1983-06-15 | Schering Corporation | Beclomethasone ester solvates, process for their preparation, and preparation of a formulation |
FI63672C (fi) * | 1980-05-19 | 1983-08-10 | Orion Yhtymae Oy | Foerfarande foer framstaellning av en blandning av beklometasondipropionat och triklorfluormetan eller diklordifluormetan |
KR880001237B1 (ko) | 1984-07-25 | 1988-07-12 | 호비온 인터 리미티드 | 베클로메타손 17,21-디프로피오네이트의 용매화합물의 제조방법 |
GB8432063D0 (en) | 1984-12-19 | 1985-01-30 | Riker Laboratories Inc | Physically modified steroids |
GB8828477D0 (en) * | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
DE69131867T2 (de) | 1990-03-23 | 2000-05-18 | Minnesota Mining & Mfg | Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe |
EP0536235B1 (en) * | 1990-06-29 | 1997-01-22 | FISONS plc | Pressurised aerosol compositions |
DK0553298T3 (da) * | 1990-10-18 | 1995-04-18 | Minnesota Mining & Mfg | Aerosolformulering omfattende beclomethason-17,21-dipropionat |
PT656207E (pt) * | 1991-06-10 | 2001-11-30 | Schering Corp | Formulacoes de aerossois sem clorofluorocarbonetos |
JPH06508149A (ja) * | 1991-06-10 | 1994-09-14 | シェリング・コーポレーション | クロロフルオロカーボン不含エーロゾル製剤 |
-
1993
- 1993-07-29 MX MX9304585A patent/MX9304585A/es not_active IP Right Cessation
- 1993-07-30 JP JP6504996A patent/JPH07509475A/ja active Pending
- 1993-07-30 EP EP93917708A patent/EP0658101B1/en not_active Expired - Lifetime
- 1993-07-30 AU AU47050/93A patent/AU670616B2/en not_active Ceased
- 1993-07-30 WO PCT/EP1993/002040 patent/WO1994003153A1/en active IP Right Grant
- 1993-07-30 AT AT93917708T patent/ATE162709T1/de not_active IP Right Cessation
- 1993-07-30 DE DE69333187T patent/DE69333187T2/de not_active Expired - Fee Related
- 1993-07-30 EP EP97101101A patent/EP0775484B1/en not_active Expired - Lifetime
- 1993-07-30 AT AT97101101T patent/ATE248582T1/de not_active IP Right Cessation
- 1993-07-30 CN CN93116824A patent/CN1052401C/zh not_active Expired - Fee Related
- 1993-07-30 DK DK93917708T patent/DK0658101T3/da active
- 1993-07-30 DE DE69316760T patent/DE69316760T2/de not_active Expired - Fee Related
- 1993-07-30 ES ES97101101T patent/ES2206619T3/es not_active Expired - Lifetime
- 1993-07-30 ES ES93917708T patent/ES2112988T3/es not_active Expired - Lifetime
-
1998
- 1998-02-20 GR GR980400363T patent/GR3026185T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN1052401C (zh) | 2000-05-17 |
DE69333187D1 (de) | 2003-10-09 |
DE69316760T2 (de) | 1998-06-04 |
EP0775484A1 (en) | 1997-05-28 |
AU670616B2 (en) | 1996-07-25 |
ES2112988T3 (es) | 1998-04-16 |
EP0658101A1 (en) | 1995-06-21 |
DE69316760D1 (de) | 1998-03-05 |
DE69333187T2 (de) | 2004-07-15 |
ES2206619T3 (es) | 2004-05-16 |
CN1088436A (zh) | 1994-06-29 |
EP0658101B1 (en) | 1998-01-28 |
ATE248582T1 (de) | 2003-09-15 |
MX9304585A (es) | 1994-03-31 |
AU4705093A (en) | 1994-03-03 |
GR3026185T3 (en) | 1998-05-29 |
ATE162709T1 (de) | 1998-02-15 |
EP0775484B1 (en) | 2003-09-03 |
DK0658101T3 (da) | 1998-09-21 |
WO1994003153A1 (en) | 1994-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07509475A (ja) | 医薬 | |
JP3675474B2 (ja) | 医薬 | |
KR100278339B1 (ko) | 제약 에어로졸 제제 | |
JP3026841B2 (ja) | 医 薬 | |
EP0616525B1 (en) | Pharmaceutical aerosol formulation | |
US5683676A (en) | Canister containing aerosol formulations containing P134a and particulate medicaments | |
US5674471A (en) | Aerosol formulations containing P134a and salbutamol | |
US20050232873A1 (en) | Aerosol formulation containing particulate formoterol, propellant and polar cosolvent | |
JPH10506887A (ja) | 医薬品 | |
US6013245A (en) | Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant | |
JPH05500664A (ja) | 医療用エアロゾル製剤 | |
PT799024E (pt) | Aerossol farmaceutico contendo pelo menos um acucar | |
JP2000515536A (ja) | エアゾール製剤 | |
US5833950A (en) | Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate | |
AU699677B2 (en) | Surfactant free aerosol formulations containing beclomathasone dipropionate | |
CA2141039C (en) | Surfactant free aerosol formulations containing beclomethasone dipropionate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040216 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040329 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040518 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050816 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20051109 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20051226 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060216 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060411 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060630 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060814 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061011 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20061212 |